5-[5-fluoro-2-[[6-(morpholin-4-ylmethyl)pyridin-3-yl]amino]pyrimidin-4-yl]-2-[(1R)-3-fluoro-1-oxidopyrrol-1-ium-1-yl]pyridine-3-carbonitrile

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 5-[5-fluoro-2-[[6-(morpholin-4-ylmethyl)pyridin-3-yl]amino]pyrimidin-4-yl]-2-[(1R)-3-fluoro-1-oxidopyrrol-1-ium-1-yl]pyridine-3-carbonitrile
• 化学式: C24H20F2N8O2
• 分子量: 490.5
• InChiKey: HRKQHYLYQVHFNY-UUWRZZSWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  36
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  118
• 氢给体数：
  1
• 氢受体数：
  11

文献信息

• PYRIMIDINE COMPOUNDS USEFUL IN THE TREATMENT OF DISEASES MEDIATED BY IKKE AND/OR TBK1 MECHANISMS
  申请人：Domainex Limited

  公开号：EP2958910A1

  公开（公告）日：2015-12-30
• [EN] PYRIMIDINE COMPOUNDS USEFUL IN THE TREATMENT OF DISEASES MEDIATED BY IKKE AND/OR TBK1 MECHANISMS<br/>[FR] COMPOSÉS PYRIMIDINE UTILES DANS LE TRAITEMENT DE MALADIES MÉDIÉES PAR LES MÉCANISMES DES IKK&Egr; ET/OU TBK-1
  申请人：DOMAINEX LTD

  公开号：WO2014128486A1

  公开（公告）日：2014-08-28

  Compounds of the general formula (I) and salts thereof are useful in the treatment of diseases associated with aberrant activity of the protein kinases ΙΚΚε and/or TBK-1 in which one of V and W is N, and the other of V and W is C-H; and R1, R2, R3 and R4 are as defined in the specification. The invention also provides uses of the compounds and compositions containing them.